Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy

Current cancer therapies have encountered adverse response due to poor therapeutic efficiency, severe side effects and acquired resistance to multiple drugs. Thus, there are urgent needs for finding new cancer-targeted pharmacological strategies. In this review, we summarized the current understandi...

Full description

Bibliographic Details
Main Authors:	Bin-Bin Li, Bo Wang, Cheng-Ming Zhu, Di Tang, Jun Pang, Jing Zhao, Chun-Hui Sun, Miao-Juan Qiu, Zhi-Rong Qian
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2019-09-01
Series:	Chronic Diseases and Translational Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095882X19300714

Similar Items

Cyclin-dependent kinase inhibitors: efficacy and safety
by: I. B. Kononenko, et al.
Published: (2019-06-01)

Anti-angiogenic effects of Cyclin dependent kinase inhibitors
by: Liebl, Johanna
Published: (2008)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
by: Gaia Giannone, et al.
Published: (2019-05-01)

Isosteres of sulfonamide inhibitors of cyclin-dependent kinases (CDKs)
by: Henderson, Andrew
Published: (2005)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
by: Paweł Łukasik, et al.
Published: (2021-03-01)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
by: M. Strnad, et al.
Published: (2001-01-01)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
by: Shaian Tavakolian, et al.
Published: (2020-05-01)

STRUCTURAL BIOINFORMATICS STUDY OF CYCLIN-DEPENDENT KINASES COMPLEXED WITH INHIBITORS
by: F. CANDURI, et al.
Published: (2018-05-01)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
by: M. Strnad, et al.
Published: (2001-01-01)

Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology
by: Karamitrousis Evangelos, et al.
Published: (2020-04-01)

Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms
by: Bin Wang, et al.
Published: (2021-05-01)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018-04-01)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
by: Aisha Alsfouk
Published: (2021-01-01)

The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.
by: Tomohito Tanaka, et al.
Published: (2017-01-01)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
by: DePamphilis Melvin L, et al.
Published: (2009-06-01)

The inhibitors of cyclin-dependent kinases and GSK-3β enhance osteoclastogenesis
by: Yosuke Akiba, et al.
Published: (2016-03-01)

Efficient activation of reconstructed rat embryos by cyclin-dependent kinase inhibitors.
by: Robin L Webb, et al.
Published: (2010-03-01)

Structure-activity relationships for alkoxypirimidine inhibitors of cyclin-dependent kinases (CDK’s)
by: Marchetti, Francesco
Published: (2009)

Investigation of the molecular mechanism of action of novel cyclin-dependent kinase inhibitors
by: Barlow, Clare Stephanie
Published: (2009)

The design and synthesis of pyrimidine based cyclin-dependent kinase (CDK) inhibitors
by: Parsons, Rachel
Published: (2001)

Structure of the cyclin-dependent kinase inhibitor p19^INK⁴^d
by: Luh, Frederick Yatlin
Published: (1998)

Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3
by: Hare, Shannagh
Published: (2014)

Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent
by: Afzal Hussain, et al.
Published: (2017-09-01)

Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
by: Hsin-Chieh Tang, et al.
Published: (2014-01-01)

Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
by: Caroline von Achenbach, et al.
Published: (2020-12-01)

Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs
by: Jennifer A. Cartwright, et al.
Published: (2019-02-01)

Computational approaches in the development of cyclin-dependent kinase 2 inhibitors for the treatment of cancer
by: Sykora, Vladimir
Published: (2009)

Analysis of cyclin dependent kinases in Leishmania
by: Gomes, Felipe Campelo
Published: (2007)

Characterization of Arabidopsis cyclin dependent kinases
by: Kitsios, Georgios
Published: (2006)

Meiotic regulation of cyclin-dependent kinases
by: Miller, Matthew P., Ph. D. (Matthew Paul). Massachusetts Institute of Technology
Published: (2013)

Cyclin-dependent kinases in <it>C. elegans</it>
by: Boxem Mike
Published: (2006-05-01)

Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
by: Kailin Li, et al.
Published: (2021-09-01)

CycD cyclins and cyclin-dependent kinases in tobacco BY-2 cells
by: Sorrell, David Andrew
Published: (1999)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
by: Hangzhan Ma, et al.
Published: (2021-02-01)

Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
by: Z. Ping Lin, et al.
Published: (2018-08-01)

Correlation of serum concentration cyclin-dependent kinase 4 and cyclin-dependent kinase 6 with breast cancer in Babylon province
by: Dalya Shakir Al-Owaidi, et al.
Published: (2020-01-01)

Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
by: Marion Peyressatre, et al.
Published: (2015-01-01)

Studies of arabidopsis cyclin-dependent kinase inhibitors : protein-protein interactions, phosphorylation and stability
by: Chan, Ron
Published: (2007)

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
by: Shu-Fu Lin, et al.
Published: (2017-01-01)

Functional characterization of the cyclin-dependent kinase inhibitor p21 by gene targeting in the mouse
by: Brugarolas, James (James Burfau), 1969-
Published: (2009)